At INTERPHEX 2026 in New York, George Kwiecinski, CEO and co-founder of Global Key Solutions Corp, discussed how AI reshapes FDA regulatory compliance and GMP inspection strategy in an interview with PharmTech. He explained that limited inspection capacity, evolving QMSR
